Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 3150-3154, August 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lippman, M. E.
Right arrow Articles by Hochberg, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lippman, M. E.
Right arrow Articles by Hochberg, R. B.

Specific Estrogen Receptor Binding and Biological Effects of 16{alpha}-Iodoestradiol on Human Breast Cancer Cells1

Marc E. Lippman, Hoan M. T. Do and Richard B. Hochberg2

Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205 [M. E. L., H. M. T. D.], and Departments of Obstetrics and Gynecology, Molecular Biophysics, and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06510 [R. B. H.]

16{alpha}-lodoestradiol was evaluated as an estrogen in MCF-7 and ZR-75-1 human breast cancer cells. 16{alpha}-[125I]lodoestradiol binds to equivalent numbers of specific estrogen receptors with a comparable binding affinity and similar sucrose density gradient behavior. 16{alpha}-lodoestradiol translocates receptor sites to the nucleus and induces a full range of estrogenic effects including thymidine incorporation, cell growth, and progesterone receptor. Because of its high specific activity, this compound may have unique applications on imaging of estrogen receptor-containing cells and specific receptor-mediated cytotoxicity.

1 This research supported in part by USPHS Grants R01 CA-29591 and K04 CA-00752 and by a grant from the Orentrich Foundation for the Advancement of Science.

2 To whom requests for reprints should be addressed.

Received 3/27/80. Accepted 5/13/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.